MRI Scan Early after Implantation of an MRI Conditional Implantable Cardioverter-Defibrillator: Case Report

Main Article Content

S. Chitnis Nishad


Introduction: MRI scans are not recommended for the first four weeks after device implantation. However, conditions like hypoxic-ischaemic encephalopathy can only be evaluated by MRI. A case where MRI brain was done in a patient with HIE four days after ICD implantation has been reported.

Case History: A 54 year old male with old anterior wall myocardial infarction presented with recurrent monomorphic, pulseless ventricular tachycardia. Anti-arrhythmic treatment resulted in severe junctional bradycardia for which temporary pacemaker was inserted. After 48 hours of stability, Medtronic Evera MRI XT DR SureScanTM Series DDMB2D1 implantable cardiovertor-defibrillator was implanted. During implantation, patient had ventricular fibrillation requiring prolonged (Comprehensive Cardiac Rehabilitation) CCR for 45 minutes.

Post-procedure, he remained comatose for more than 48 hours. Bedside EEG showed mild to moderate generalised encephalopathy which did not match the clinical picture. Therefore, MRI brain was done on fourth day after implant taking risk consent from the patient’s wife. The MRI scan was done safely using SureScan mode. It showed mild changes of hypoxic encephalopathy suggesting a decent prognosis. The ICD lead positions and parameters were rechecked and found to be optimum.

The patient slowly recovered over three weeks. He needed dialysis for acute kidney injury, antibiotics for ventilator associated pneumonia, tracheostomy for ventilation and percutaneous endoscopic gastrostomy for feeding. He was discharged with percutaneous endoscopic gastrostomy (PEG) in-situ and improving neurological status.

Conclusion: While a single case cannot make a recommendation, this case demonstrates that it not impossible to do an MRI scan safely in a patient very shortly after an ICD implant if the clinical situation warrants it.

Implantable cardioverter-defibrillator, ventricular tachycardia, MRI scan, hypoxic ischaemic encephalopathy.

Article Details

How to Cite
Nishad, S. C. (2019). MRI Scan Early after Implantation of an MRI Conditional Implantable Cardioverter-Defibrillator: Case Report. Asian Journal of Cardiology Research, 2(2), 1-8. Retrieved from
Case Report


Horwood L, Attili A, Luba F, Ibrahim EH, Parmar H, Stojanovska J, et al. Magnetic resonance imaging in patients with cardiac implanted electronic devices: Focus on contraindications to magnetic resonance imaging protocols. Europace. 2017;19(5): 812-7.

Kodali S, Baher A, Shah D. Safety of MRIs in patients with pacemakers and defibrillators. Methodist Debakey Cardiovasc J. 2013;9(3):137-41.

Wilkoff BL, Bello D, Taborsky M, Vymazal J, Kanal E, Heuer H, et al. Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment. Heart Rhythm. 2011;8(1):65-73.

Korutz AW, Obajuluwa A, Lester MS, McComb EN, Hijaz TA, Collins JD, et al. Pacemakers in MRI for the Neuroradio-logist. AJNR Am J Neuroradiol. 2017; 38(12): z2222-30.

Russo RJ, Costa HS, Silva PD, Anderson JL, Arshad A, Biederman RW, et al. Assessing the risks associated with MRI in patients with a pacemaker or Defibrillator. N Engl J Med. 2017;376(8):755-64.

Howard RS, Holmes PA, Siddiqui A, Treacher D, Tsiropoulos I, Koutroumanidis M. Hypoxic–ischaemic brain injury: imaging and neurophysiology abnor-malities related to outcome. QJM: An International Journal of Medicine. 2012; 105(6):551-61.

Gold MR, Sommer T, Schwitter J, Al Fagih A, Albert T, Merkely B, et al. Full-body MRI in patients with an implantable cardioverter- defibrillator: Primary results of a randomized study. J Am Coll Cardiol. 2015;65(24):2581- 8.

Muttikkal TJ, Wintermark M. MRI patterns of global hypoxic-ischemic injury in adults. J Neuroradiol. 2013;40(3):164-71.

Maurya VK, Ravikumar R, Bhatia M, Rai R. Hypoxic-Ischemic brain injury in an adult: Magnetic resonance imaging findings. Med J Armed Forces India. 2016; 72(1):75-7.

Bisping HJ, Kreuzer J, Birkenheier H. Three-year clinical experience with a new endocardial screw-in lead with introduction protection for use in the atrium and ventricle. Pacing Clin Electrophysiol. 1980; 3(4):424-35.